If you're having trouble viewing this email, see it on the Web.

Posts:

Polio Monthly Situation Report–November 2009

Supply Chain Management Course for Francophone Countries

MDVP for Adjuvanted Pandemic Vaccines

Issue 33, 14 December 2009

Editorial Note

Issue 33 has the latest update on the polio situation from Sainjargal Altanzul; an announcement shared by Diana Chang Blanc regarding a Supply Chain Management Course; and a reply from Eric Marie Jean Laurent to the query on applying MDVP to adjuvanted pandemic vaccines.

Polio Monthly Situation Report–November 2009
by Sainjargal Altanzul

The Advisory Committee on Poliomyelitis Eradication (ACPE) held a special consultation in Geneva on 18-19 November. It evaluated the impact of the 2009 Programme of Work, including the Independent Evaluation of Major Barriers to Interrupting Poliovirus Transmission, reviewed the outcomes of the clinical trials on the new bivalent oral polio vaccine (bOPV) and looked closely at the epidemiological trends in the remaining four endemic countries, as well as the measures put in place to limit international spread of wild poliovirus. These discussions mark the start of a wide-ranging consultative process for the development of a new Programme of Work ... The full recommendations of the ACPE are available at www.polioeradication.org and will be published in the WHO Weekly Epidemiological Report in January.

[Read more]

Comment on this post by email or on the web

Supply Chain Management Course for Francophone Countries

The Institut Bioforce Développement announces the “Overview Course in Supply Chain Management of Health Commodities", a new training programme designed to help health sector professionals understand logistics management and commodity planning better. It also seeks to improve their ability to manage health commodities.

The training will be conducted in French and is intended for individuals who are responsible for planning, managing, monitoring or procuring commodity supply chains for HIV prevention and treatment, malaria, family planning or other national health programmes, in the public, NGO or private sector. The training will take place in Ouagadougou, Burkina Faso from the 22nd to the 27th of March 2010. It will extend over 6 days and will cost 1800 euros.

The training is being offered in partnership with the USAID-DELIVER project and the World Health Organization (WHO).

[Read more]

Comment on this post by email or on the web

MDVP for Adjuvanted Pandemic Vaccines
by Eric Marie Jean Laurent

The manufacturer has confirmed that Focetria contains the regular amount of thimerosal.

However, at this stage, as we are still working on the review of the Summary of Product Characteristics and the stability aspects, we would recommend NOT to apply the MDVP policy until we get more information.

[Read more]

Comment on this post by email or on the web

Photos Courtesy: Ranjit Dhiman

	Web Highlights:
		The State of the World’s Children Special Edition
		Expanding immunization coverage in rural India: A review of evidence for the role of community health workers
		Vaccination push as polio re-emerges
		Advocacy for Immunization Program receives a three-year grant from the Bill & Melinda Gates Foundation
		GAVI honours 15 countries for excelling in immunisation and child survival

If you have contributions to make or thoughts to share with others on TechNet21, you can write to the moderator or post directly on the web forums. Click here to change your subscription settings or unsubscribe from the mailing list.

TechNet21 is generously supported by the Bill and Melinda Gates Foundation, under the oversight of WHO and UNICEF. The information in this forum is provided by users, as a service. All contributions are reviewed prior to posting, and all postings are attributed to the authors. The details given in emails will not be voluntarily shared or sold to any outside company and will only be used for verification and to identify postings, if necessary. The authors are solely responsible for their submissions, and the readers are solely responsible for the interpretation of these submissions. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to this forum.

For posts where the author is a WHO staff member, the author alone is reponsible for the views expressed and they do not necessarily represent the decisions, guidelines, recommendations or policies of WHO.